Kubota Pharmaceutical Holdings Co. Ltd.

As of June 30, 2026, Kubota Pharmaceutical Holdings Co. Ltd. carries a market capitalization of 8.42B, placing it among publicly traded companies globally. Its enterprise value stands at 6.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Kubota Pharmaceutical Holdings Co. Ltd.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Kubota Pharmaceutical Holdings Co. Ltd. has 153.14M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Kubota Pharmaceutical Holdings Co. Ltd. maintains a current ratio of 10.19, meaning it holds 10.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Kubota Pharmaceutical Holdings Co. Ltd.'s stock has declined approximately 6.25% over the past 52 weeks. The 50-day moving average sits at 65.18, while the 200-day moving average is 84.65.

As of June 30, 2026, Kubota Pharmaceutical Holdings Co. Ltd. holds 1.58B in cash and equivalents against 78.32M in total debt, resulting in a net debt position of -1.52B. Total book value stands at 1.60B, with working capital of 1.59B providing operational flexibility.